- Zacks•15 hours ago
Medical is expected to reverse the trend with ease as earnings are expected to grow 1.8% driven by impressive top-line growth of 7.7% for the quarter.
- Investor's Business Daily•21 hours ago
The two largest biotechnology ETFs are poised at a critical juncture in their troubled growth story.
Edwards Lifesciences Corp.NYSE
After hours: 106.520.00 (0.00%) as of 7:53 PM EDT
|Bid||98.70 x 100|
|Ask||107.00 x 100|
|52wk Range||62.53 - 112.00|
|Day's Range||105.57 - 106.66|
|Avg Vol (3m)||1,665,444|
As of 4:02 PM EDT. Market closed.